Every year, more than 5,000 Americans receive a diagnosis of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that leads to paralysis. Despite its impact, the exact number of ALS cases in the United States remains uncertain, and the causes of most cases are unknown. The U.S. National ALS Registry, established to address these gaps, is urging individuals living with ALS to enroll and contribute data that could shape future research and treatment.
The registry, managed by the Centers for Disease Control and Prevention (CDC), collects and analyzes data from people with ALS across the country. "The National ALS Registry is a program of, by and for those living with ALS," said Dr. Paul Mehta, principal investigator of the Registry. "The program collects, manages and analyzes data about people with ALS in the United States. It includes data and information provided by individuals who choose to register and complete the risk factor surveys."
The primary goal of the registry is to gather information that can be used to estimate the number of new ALS cases diagnosed each year, determine how many people have ALS at any given time, better understand who gets ALS and what factors affect the disease, and enhance research that could improve care. Since 2010, the registry has funded more than a dozen studies exploring potential risk factors, such as occupational history and environmental exposures.
Individuals with ALS can participate by completing up to 18 risk factor surveys, which help create a more comprehensive picture of their experience with the disease. By sharing their stories and data, enrollees contribute to a growing body of evidence that researchers use to identify patterns and potential causes. "By joining and taking the risk factor surveys, individuals living with ALS can help future generations," the registry emphasizes.
Enrollment is open to anyone living with ALS. Those interested can get started at cdc.gov/als. The registry's efforts are especially highlighted during ALS Awareness Month, as advocates seek to increase participation and accelerate progress toward understanding and treating this devastating disease.
The registry not only serves as a critical resource for researchers but also empowers patients to take an active role in advancing science. By contributing data, participants help ensure that future research is grounded in real-world experiences, potentially leading to breakthroughs in care and prevention.
